Polycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic
disorders in premenopausal women. Heterogeneous by nature, PCOS is defined by a …

Context Obesity is responsible for an increased risk of sub-fecundity and infertility. Obese
women show poorer reproductive outcomes regardless of the mode of conception, and …

Polycystic ovary syndrome (PCOS) has multiple etiologies including ovarian and adrenal
hyperandrogenism, neuro-endocrine and hypothalamic-pituitary dysfunction, and disorders …

Insulin resistance is documented in clamp studies in 75% of women with polycystic ovary
syndrome (PCOS). Although it is not included in the diagnostic criteria of PCOS, there is a …

Purpose Polycystic ovary syndrome (PCOS) is the most common endocrine disorder that
affects women of reproductive age and is characterized by ovulatory dysfunction and/or …

Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of
reproductive age. Metabolic sequelae associated with PCOS range from insulin resistance …

Women with polycystic ovary syndrome (PCOS) were treated with the GLP‐1 receptor
agonist liraglutide to investigate the effect on liver fat content, visceral adipose tissue (VAT) …

This meta-analysis aimed to evaluate the efficacy and safety of glucagon-like peptide 1 (GLP-
1) receptor agonists for women with polycystic ovary syndrome (PCOS) by comparing their …

Objective To evaluate the efficacy of insulin sensitizers on menstrual frequency, sex
hormone, and metabolic parameters in overweight women with polycystic ovary syndrome …

Abstract BACKGROUND Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1 RAs)
have become firmly established in the treatment of type 2 diabetes and obesity, disorders …